中国肝静脉压力梯度临床应用专家共识(2018版)

作者:Chinese Portal Hypertension Diagnosis; Monitoring Study Group; Minimally Invasive Intervention Collaborative Group; Chinese Society of Gastroenterology; Emergency Intervention Committee; Chinese College of Interventionalists; Hepatobiliary Diseases Collaborative Group; Chinese Society of Gastroenterology; Spleen; Portal Hypertension Group; Chinese Society of Surgery; Fatty Liver; Alcoholic Liver Disease Group; Chineses Society of Hepatology
来源:现代医药卫生, 2019, 35(01): 160-170.

摘要

<正>门静脉高压是影响肝硬化患者临床预后的重要因素,其严重程度决定了肝硬化并发症(如食管胃静脉曲张破裂出血、腹腔积液、肝肾综合征等)的发生和发展[1-2]。据报道,我国肝病患者人数已超过4亿,是全球肝病负担最重的国家,其中乙型病毒性肝炎表面抗原阳性或丙型病毒性肝炎抗体阳性者约1.06亿,酒精性肝病人群约6 000万,非酒精性脂肪性肝病患

  • 单位
    中华医学会